Assessing the Role of Exercise Intensity in Slowing Disease Progression in Early Parkinson’s Disease

Parkinson's Disease Clinical Trial

Official title:

Assessing the Role of Exercise Intensity in Slowing Disease Progression in Early Parkinson’s Disease

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00385073
• Other study ID #: 126/05
• Status: Recruiting
• Phase: N/A
• First received: October 5, 2006
• Last updated: October 5, 2006
• Start date: April 2005
• Est. completion date: December 2007

Study information

• Verified date: October 2006
• Source: Austin Health
• Contact: mary m Galea, PhD
• Phone: 0061383444171
• Email: m.galea[@]unimelb.edu.au
• Is FDA regulated: No
• Health authority: Australia: Human Research Ethics Committee
• Study type: Observational

Clinical Trial Summary

Participants will complete a self-selected intensity of exercising over a 6 month period, with detailed clinical assessments at commencement and completion to determine the rate of progression of parkinsonism and gait abnormalities

Description:

Participants will complete a self-selected intensity of exercising over a 6 month period - including jogging, swimming and circuit training, with detailed clinical assessments at commencement and completion (including UPDRS, gaitrite lab study) to determine the rate of progression of parkinsonism and gait abnormalities

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Est. completion date: December 2007
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Early Parkinson's Disease,

• Able to provide informed consent,

• able to complete exercise diaries for 6 months,

• no medications or on levo-dopa

Exclusion Criteria:

• Not on dopamine agonists,

Study Design

Observational Model: Defined Population, Time Perspective: Longitudinal

Related Conditions & MeSH terms

• Disease Progression
• Parkinson Disease
• Parkinson's Disease

Locations

Country	Name	City	State
Australia	Royal Talbot Rehabilitation Centre	Melbourne

Sponsors (1)

Lead Sponsor	Collaborator
Austin Health

Country where clinical trial is conducted

Australia,